Home
About
Overview
Sharing Data
ORCID
Help
History (9)
What's LPS Got to Do with It? A Role for Gut LPS Variants in Driving Autoimmune and Allergic Disease.
tRNA Misacylation with Methionine in the Mouse Gut Microbiome in Situ.
Oral Polyphosphate Suppresses Bacterial Collagenase Production and Prevents Anastomotic Leak Due to Serratia marcescens and Pseudomonas aeruginosa.
A phase 1B study of dulanermin in combination with modified FOLFOX6 plus bevacizumab in patients with metastatic colorectal cancer.
Targeting megakaryocytic-induced fibrosis in myeloproliferative neoplasms by AURKA inhibition.
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Targeting megakaryocytic-induced fibrosis in myeloproliferative neoplasms by AURKA inhibition.
Targeting megakaryocytic-induced fibrosis in myeloproliferative neoplasms by AURKA inhibition. Nat Med. 2015 Dec; 21(12):1473-80.
View in:
PubMed
subject areas
Animals
Antigens, CD34
Apoptosis
Aurora Kinase A
Azepines
Blotting, Western
Cell Differentiation
Cell Line, Tumor
Cell Proliferation
Cost of Illness
Disease Models, Animal
Drug Synergism
Heterozygote
Inhibitory Concentration 50
Janus Kinase 2
Megakaryocytes
Mice
Mutation
Nitriles
Polyploidy
Primary Myelofibrosis
Protein Kinase Inhibitors
Proto-Oncogene Proteins c-myc
Pyrazoles
Pyrimidines
Receptors, Thrombopoietin
Signal Transduction
authors with profiles
Sandeep Gurbuxani